Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA was delisted on the 7th of June, 2023.
35 hedge funds and large institutions have $104M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 12 closing their positions.
4% less capital invested
Capital invested by funds: $108M → $104M (-$4.62M)
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
22% less funds holding
Funds holding: 45 → 35 (-10)
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Commodore Capital
New York
|
+$3.01M |
| 2 |
SC
Samlyn Capital
New York
|
+$273K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$197K |
| 4 |
State Street
Boston,
Massachusetts
|
+$88.6K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$42.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$805K |
| 2 |
MS
Maven Securities
St Helier,
Jersey
|
-$730K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$422K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$366K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$347K |
STSA Hedge Fund Activity: Q4 2021 in Review
35 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Satsuma Pharmaceuticals, Inc. Common Stock (STSA) for Q4 2021, worth a combined $104M — down 4.3% from $108M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of STSA and 4 opened new positions — a net loss of 8 holders — while 11 trimmed existing stakes and 9 added.
The largest buyer was Commodore Capital, adding an estimated $3.01M. The largest seller was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, cutting an estimated $805K.
- 35 institutional investors held Satsuma Pharmaceuticals, Inc. Common Stock (STSA) as of Q4 2021, down from 45 in Q3 2021.
- Funds reported $104M of Satsuma Pharmaceuticals, Inc. Common Stock stock for Q4 2021, down 4.3% quarter-over-quarter.
- 4 funds opened new Satsuma Pharmaceuticals, Inc. Common Stock positions in Q4 2021 and 12 closed out, a net change of -8 holders.
- The largest Satsuma Pharmaceuticals, Inc. Common Stock buyer in Q4 2021 was Commodore Capital, an estimated $3.01M added.
- The largest Satsuma Pharmaceuticals, Inc. Common Stock seller in Q4 2021 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $805K sold.
Based on aggregated 13F filings for Q4 2021.